Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Side effec ts Vagal blocka de Minimal Vagal black H i s t a mi n e r el e a s e H i s t a mi n e None; histamine Myalgia; bradyc ardia/
with large (tachycardia), release; r el eas e a t hi gh asystole in children or
doses catecholamine laudanosine and doses with repeated dosing;
release acrylates dual (phase I I,
production competitive) block;
a n a ph y l a xi s
NA: da ta no t available ; ED 9 5 : effec tive do se to achieve 95% de pression of baseline muscle contrac tion; NMBA: neuromuscular blocking a gents; RSII: ra pid s equence
in du c tio n an d in tu ba tio n; K +: po tassi um; MH : m ali gn an t hy per th ermi a; S T: si n gle tw it ch ; IC U: in t ensi ve c are uni t.
- T h e da t a a r e a v e r a ge s o bt a i n e d f r o m pu bl is h e d l i te r a tur e a n d do n o t a c c o u n t f o r o t h e r i nf lu e n c e s s u c h as v o l a t il e a n e st h e t i c s , m us c l e t e m pe r a t u r e , e t c .
Adapted from: Brull Si. Neuromuscular blocking agents. In: Clinical Anesthesia, 8th ed, Barash PE, Cullen BF, Stocking RK, eta! (Eds), Wolters Kluwer, Philadelphia 2017.
UpToDate'
Copyrights apply